ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,528.94
0.36%
Gold vs US Dollar
2,363.73
0.72%
Brent Oil
82.755
-1.42%
Bitcoin
60,587.83
-3.90%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Regenerx Biopharmaceuticals (RGN)

  7. Regenerx Biopharmaceuticals (RGN) News

Regenerx Biopharm In (RGN)

Regenerx Biopharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:RGN
DateTimeSourceHeadlineSymbolCompany
22/12/201014:16Business WireFirst Patient Screened in Phase 2 Trial with RegeneRx’s RGN-259 for Dry Eye SyndromeAMEX:RGNRegenerx Biopharmaceuticals
21/12/201021:31Edgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
20/12/201015:00Business WireRegeneRx’s Scientific Advisory Board Member Receives 2011 Camras AwardAMEX:RGNRegenerx Biopharmaceuticals
09/12/201015:51Business WireRegeneRx Receives Mexican Patent for the Use of TB4 for Prevention and Treatment of Cardiac DamageAMEX:RGNRegenerx Biopharmaceuticals
01/12/201015:30Business WireRegeneRx Receives Australian Patent Using TB4 to Protect Against Biological, Chemical and Toxic AgentsAMEX:RGNRegenerx Biopharmaceuticals
30/11/201018:41Business WireResearchers Identify Potential Thymosin Beta 4 ReceptorAMEX:RGNRegenerx Biopharmaceuticals
17/11/201014:35Business WireRegeneRx Receives Australian Patent Using Tβ4 for Treatment Of Gastrointestinal DisordersAMEX:RGNRegenerx Biopharmaceuticals
16/11/201019:30Business WireRegeneRx President and CEO to Present at Maxim Group Growth ConferenceAMEX:RGNRegenerx Biopharmaceuticals
12/11/201011:09Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
02/11/201011:30Business WireRegeneRx Reports Positive Results of Preclinical Dry Eye StudyAMEX:RGNRegenerx Biopharmaceuticals
01/11/201021:06Edgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
01/11/201020:30Business WireRegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request HearingAMEX:RGNRegenerx Biopharmaceuticals
01/11/201016:56Business WireRegeneRx Awarded $733,438 from U.S. Government Under the Patient Protection and Affordable Care ActAMEX:RGNRegenerx Biopharmaceuticals
26/10/201016:07Business WireRegeneRx Announces Letter to Stockholders Posted on WebsiteAMEX:RGNRegenerx Biopharmaceuticals
14/09/201014:08Business WireRegeneRx Announces TB4 Stroke Study to be Honored at American Heart Association Scientific SessionsAMEX:RGNRegenerx Biopharmaceuticals
07/09/201015:35Business WireRegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment ConferenceAMEX:RGNRegenerx Biopharmaceuticals
03/09/201022:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
03/09/201022:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:RGNRegenerx Biopharmaceuticals
02/09/201013:44Edgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
02/09/201012:00Business WireRegeneRx Appoints R. Don Elsey to Board of DirectorsAMEX:RGNRegenerx Biopharmaceuticals
20/08/201021:01Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:RGNRegenerx Biopharmaceuticals
13/08/201011:02Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
02/08/201013:30Business WireBritish Researchers Report that TB4 is Essential to Heart DevelopmentAMEX:RGNRegenerx Biopharmaceuticals
21/07/201021:48Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)AMEX:RGNRegenerx Biopharmaceuticals
20/07/201022:26Edgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
19/07/201017:30Business WireResearchers Report in Neuroscience that TB4 Improves Neurological Function after StrokeAMEX:RGNRegenerx Biopharmaceuticals
16/07/201022:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
16/07/201022:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
16/07/201022:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
16/07/201022:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
 Showing the most relevant articles for your search:AMEX:RGN

Your Recent History

LSE
POS
Plexus
LSE
TERN
Tern
LSE
SYME
Supply@me Capital
LSE
PET
Petrel Resources
LSE
AAZ
Anglo Asian Mining
LSE
SFOR
S4 Capital
LSE
ITV
Itv
LSE
RR.
Rolls-royce
LSE
THG
Thg
LSE
AGL
Angle
LSE
BOO
Boohoo
LSE
POLX
Polarean Imaging
LSE
PANR
Pantheon Resources
LSE
TXP
Touchstone Exploration
LSE
GKP
Gulf Keystone Petroleum
LSE
CHLL
Chill Brands
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved